14 Grants
2008
PILOT PHASE I STUDY OF DECAFFEINATED GREEN TEA CONCENTRATE AND CAPSICUM VANILLOI
LOGAN, THEODORE F
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000750-36-7673), $305USD, 12/01/2007 -- 05/31/2008
2007
PILOT PHASE I STUDY OF DECAFFEINATED GREEN TEA CONCENTRATE AND CAPSICUM VANILLOI
LOGAN, THEODORE F
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000750-35-8366), $3,594USD, 12/01/2006 -- 11/30/2007
2004
Trial of Weekly Low Dose Taxotere in pts with metastatic malignant melanoma.
LOGAN, THEODORE F
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000750-32-7638), $748USD, 12/01/2003 -- 11/30/2004
2000
PHASE II STUDY OF IN VITRO SENSITIZATION IN MELANOMA/RENAL CELL CARCINOMA PTS
LOGAN, THEODORE
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000056-39-0597), $3,034USD, 2000
 
PHASE I STUDY OF IN VITRO SENSITIZATION UTILIZING ANTI-CD3 STIMULATED LYMPHOCYTES
LOGAN, THEODORE
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000056-39-0612), $3,034USD, 2000
1999
PHASE II STUDY OF IN VITRO SENSITIZATION IN MELANOMA/RENAL CELL CARCINOMA PTS
LOGAN, THEODORE
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 3M01RR000056-38S3-0597), 12/01/1998 -- 11/30/1999
 
PHASE II STUDY OF IN VITRO SENSITIZATION IN MELANOMA/RENAL CELL CARCINOMA PTS
LOGAN, THEODORE
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 3M01RR000056-38S1-0597), 12/01/1978 -- 11/30/2003
 
PHASE I STUDY OF IN VITRO SENSITIZATION UTILIZING ANTI-CD3 STIMULATED LYMPHOCYTES
LOGAN, THEODORE
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 3M01RR000056-38S1-0612), 12/01/1978 -- 11/30/2003
 
PHASE I STUDY OF IN VITRO SENSITIZATION UTILIZING ANTI-CD3 STIMULATED LYMPHOCYTES
LOGAN, THEODORE
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 3M01RR000056-38S3-0612), 12/01/1998 -- 11/30/1999
1998
PHASE II STUDY OF IN VITRO SENSITIZATION IN MELANOMA/RENAL CELL CARCINOMA PTS
LOGAN, THEODORE
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000056-37-0597), 12/01/1997 -- 11/30/1998
 
PHASE I STUDY OF IN VITRO SENSITIZATION UTILIZING ANTI-CD3 STIMULATED LYMPHOCYTES
LOGAN, THEODORE
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000056-37-0612), 12/01/1997 -- 11/30/1998
1997
PHASE II STUDY OF IN VITRO SENSITIZATION IN MELANOMA/RENAL CELL CARCINOMA PTS
LOGAN, THEODORE
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000056-36-0597), 03/18/1997 -- 11/30/1997
 
PHASE I STUDY OF IN VITRO SENSITIZATION UTILIZING ANTI-CD3 STIMULATED LYMPHOCYTES
LOGAN, THEODORE
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000056-36-0612), 03/18/1997 -- 11/30/1997
1996
PH-I OF INTERLEUKIN-1 ALPHA AND CARBOPLATIN IN PATIENTS WITH METASTATIC DISEASE
LOGAN, THEODORE
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 5M01RR000056-35), 1996